Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06614218
MIMS® Retrospective Chart Review
Sponsor: Sanoculis Ltd
View on ClinicalTrials.gov
Summary
This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.
Official title: Minimally Invasive Micro Sclerostomy (MIMS®) Retrospective Chart Review
Key Details
Gender
All
Age Range
40 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-02-01
Completion Date
2026-01-01
Last Updated
2025-01-10
Healthy Volunteers
Not specified
Conditions
Interventions
DEVICE
Minimally Invasive Micro Sclerostomy
The MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the eye.
Locations (1)
S. Malayan Eye Center
Yerevan, Armenia